STIMQ NEUROSTIMULATOR
Report
- Report Number
- 3010676138-2020-00172
- Event Type
- Injury
- Date Received
- December 16, 2020
- Date of Event
- November 16, 2020
- Report Date
- November 16, 2020
- Manufacturer
- STIMWAVE TECHNOLOGIES INC.
- Product Code
- GZF
- PMA / PMN Number
- K171366
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- BIOMEDICAL ENGINEER
Narratives
THE PATIENT REPORTED ATTENDING A FOLLOW-UP APPOINTMENT WITH A PRIMARY CARE PHYSICIAN, WHO ADVISED THE PATIENT TO FOLLOW-UP WITH THE IMPLANTING CLINICIAN BECAUSE THE WOUND SEEMED TO BE INFECTED AND ONE OF THE LEADS APPEARED TO BE ERODING. THE PATIENT REACHED OUT TO THE CLINICAL REPRESENTATIVE IMMEDIATELY. THE CLINICAL REPRESENTATIVE RECOMMENDED THE PATIENT CALL THE IMPLANTING CLINICIAN'S OFFICE AND SCHEDULE A FOLLOW-UP. ON (B)(6) 2020, THE PATIENT WAS SEEN BY ONE OF THE ASSOCIATES OF THE IMPLANTING CLINICIAN, WHO DETERMINED THAT THE TAIL OF THE LEAD WAS PROTRUDING OUT OF THE PATIENT'S INCISION AND RECOMMENDED THE LEADS BE REMOVED AND RE-IMPLANTED. THE PATIENT WAS INSTRUCTED TO FOLLOW-UP WITH THE IMPLANTING CLINICIAN ON (B)(6) 2020, TO DISCUSS FURTHER OPTIONS. THE PHYSICIAN DID NOT PRESCRIBE ORAL ANTIBIOTICS. ON (B)(6) 2020, THE IMPLANTING CLINICIAN CANCELED THE FOLLOW-UP APPOINTMENT WITH THE PATIENT. THE IMPLANTING CLINICIAN TOLD THE PATIENT THAT THE PLAN IS TO EXPLANT AND IMPLANT NEW LEADS IMMEDIATELY AFTER BWC GRANTS THE APPROVAL. THE PROCEDURE WAS REPORTED TO HAVE BEEN PERFORMED PER THE PRODUCT IFU. STIMWAVE HAS CONFIRMED THAT THE PRODUCT WAS DELIVERED STERILE, VALIDATED STERILIZATION PARAMETERS WERE USED, AND STERILE BARRIERS WERE VERIFIED TO BE INTACT FOLLOWING PACKAGING. BASED ON THIS INFORMATION, THE EROSION WAS CONFIRMED/REPLICATED, AND THERE IS NO EVIDENCE THAT THE PRODUCT DID NOT MEET SPECIFICATIONS. THE STIMULATOR IS USED TO TREAT PAIN. THE CAUSE OF THE INFECTION AND EROSION COULD NOT BE CONCLUDED WITH THE AVAILABLE INFORMATION (NO PROBLEM FOUND).
ON (B)(6) 2020, THE CLINICAL REPRESENTATIVE WAS MADE AWARE THAT A RECENTLY IMPLANTED PATIENT WAS SUSPECT OF POTENTIAL INFECTION AND EROSION AT THE WOUND SITE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1486508 | STIMQ NEUROSTIMULATOR | PERIPHERAL NERVE STIMULATOR | GZF | STIMWAVE TECHNOLOGIES INC. | STQ4-RCV-A0, STQ4-SPR-B0 | SWO200305, SWO200320 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |